{"id":2282,"date":"2023-07-04T08:09:00","date_gmt":"2023-07-04T08:09:00","guid":{"rendered":"https:\/\/dailyai.com\/?p=2282"},"modified":"2023-07-05T08:09:37","modified_gmt":"2023-07-05T08:09:37","slug":"first-ai-generated-drug-given-go-ahead-for-human-trials","status":"publish","type":"post","link":"https:\/\/dailyai.com\/es\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/","title":{"rendered":"Primer f\u00e1rmaco generado por inteligencia artificial autorizado para ensayos en humanos"},"content":{"rendered":"<p><strong>Insilico Medicine ha recibido la aprobaci\u00f3n para realizar ensayos en humanos de su f\u00e1rmaco generado completamente por IA.<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">El f\u00e1rmaco se ha dise\u00f1ado como posible tratamiento de la fibrosis pulmonar idiop\u00e1tica (FPI), enfermedad degenerativa que provoca la cicatrizaci\u00f3n y engrosamiento de los tejidos pulmonares. La FPI afecta a unas 100.000 personas s\u00f3lo en Estados Unidos. El nuevo f\u00e1rmaco, denominado INS018_055, se probar\u00e1 durante 12 semanas en China y est\u00e1 previsto ampliar los ensayos a China y Estados Unidos.<\/span><\/p>\n<p><a href=\"https:\/\/insilico.com\/\"><span style=\"font-weight: 400;\">Insilico<\/span><\/a><span style=\"font-weight: 400;\"> es una empresa de biotecnolog\u00eda con sede en Hong Kong que utiliza la IA para desarrollar nuevos medicamentos, as\u00ed como en la investigaci\u00f3n contra el envejecimiento. La aplicaci\u00f3n de la IA en sus investigaciones ha permitido un desarrollo mucho m\u00e1s r\u00e1pido de nuevos f\u00e1rmacos.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\"La IA nos permite analizar cantidades masivas de datos y encontrar conexiones que los cient\u00edficos humanos podr\u00edan pasar por alto, para luego 'imaginar' mol\u00e9culas totalmente nuevas que pueden convertirse en f\u00e1rmacos\", afirma Alex Zhavoronkov, fundador y director general de Insilico Medicine.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">La empresa utiliza la IA en cada paso de su estrategia de desarrollo de f\u00e1rmacos. Primero utilizan su herramienta de IA, llamada PandaOmics, para identificar una \"diana\" o causa biol\u00f3gica vinculada a una enfermedad concreta. Por ejemplo, el objetivo podr\u00eda ser un gen o una prote\u00edna que no funciona correctamente.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Una vez que identifican una diana, utilizan su otra plataforma de IA, Chemistry42, para dise\u00f1ar una mol\u00e9cula que rectifique el problema bloqueando la diana sin causar da\u00f1o al paciente.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">En este caso, el \"55\" del nombre del f\u00e1rmaco hace referencia a la mol\u00e9cula n\u00famero 55 que se dise\u00f1\u00f3 y result\u00f3 prometedora.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">El objetivo de los ensayos de fase II aprobados es comprobar si el f\u00e1rmaco produce una respuesta significativa en los primeros participantes. Si tiene \u00e9xito, pasar\u00e1 a los ensayos de fase III para confirmar su seguridad y eficacia antes de que la FDA pueda aprobarlo.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Insilico Medicine tiene en proyecto una serie de interesantes desarrollos farmacol\u00f3gicos basados en IA. La FDA ha aprobado recientemente la solicitud inicial de nuevo f\u00e1rmaco en investigaci\u00f3n (IND) para su medicamento contra el c\u00e1ncer dirigido a tumores s\u00f3lidos. Los ensayos de fase I est\u00e1n previstos para julio de 2023 en Estados Unidos y China.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Cuando o\u00edmos hablar de IA generativa, normalmente pensamos en im\u00e1genes, canciones o textos generados. Pero Insilico utiliza la IA generativa para identificar las dianas que causan una enfermedad y dise\u00f1ar mol\u00e9culas que se dirijan directamente a esas dianas.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Si le preguntaras a ChatGPT qu\u00e9 prote\u00ednas podr\u00edan ser el objetivo para tratar un tipo espec\u00edfico de c\u00e1ncer de mama, podr\u00eda identificarlas porque tiene acceso a la investigaci\u00f3n m\u00e9dica publicada. Insilico tiene su propio LLM llamado ChatPandaGPT que permite a los investigadores utilizar consultas en lenguaje natural para cribar en una base de conocimientos especializada grandes cantidades de datos cl\u00ednicos.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Utilizando <\/span><a href=\"https:\/\/dailyai.com\/es\/2023\/06\/researchers-create-high-performance-ai-model-to-detect-heart-disease-from-ecgs\/\"><span style=\"font-weight: 400;\">La IA en medicina<\/span><\/a><span style=\"font-weight: 400;\"> est\u00e1 ayudando a empresas como Insilico a acortar dr\u00e1sticamente el proceso de descubrimiento de f\u00e1rmacos. Su <\/span><a href=\"https:\/\/insilico.com\/pipeline\"><span style=\"font-weight: 400;\">investigaci\u00f3n en curso<\/span><\/a><span style=\"font-weight: 400;\"> tiene una interesante l\u00ednea de tratamientos potenciales para distintos tipos de c\u00e1ncer, as\u00ed como un f\u00e1rmaco COVID-19 que tambi\u00e9n est\u00e1 en ensayos de fase I.<\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>Insilico Medicine ha recibido la aprobaci\u00f3n para realizar ensayos en humanos de su f\u00e1rmaco generado completamente por IA. El f\u00e1rmaco se ha dise\u00f1ado como posible tratamiento de la fibrosis pulmonar idiop\u00e1tica (FPI), una enfermedad degenerativa que provoca la cicatrizaci\u00f3n y el engrosamiento de los tejidos pulmonares. La FPI afecta a unas 100.000 personas s\u00f3lo en Estados Unidos. El nuevo f\u00e1rmaco, denominado INS018_055, se probar\u00e1 durante 12 semanas en China y est\u00e1 previsto ampliar los ensayos a China y Estados Unidos. Insilico es una empresa biotecnol\u00f3gica con sede en Hong Kong que utiliza la IA para desarrollar nuevos medicamentos y en la investigaci\u00f3n contra el envejecimiento. La aplicaci\u00f3n de la IA en sus<\/p>","protected":false},"author":6,"featured_media":2283,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[84],"tags":[150,107,101],"class_list":["post-2282","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-industry","tag-ai-benefits","tag-generative-ai","tag-medtech"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>First AI-generated drug given go-ahead for human trials | DailyAI<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/dailyai.com\/es\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"First AI-generated drug given go-ahead for human trials | DailyAI\" \/>\n<meta property=\"og:description\" content=\"Insilico Medicine has been given approval for human trials of their completely AI-generated drug. The drug has been designed as a potential treatment for idiopathic pulmonary fibrosis (IPF) which is a degenerative disease that causes scarring and thickening of the lung tissues. IPF affects around 100,000 people in the US alone. The new drug, called INS018_055, will be trialed for 12 weeks in China with expanded trials planned for China and the US. Insilico is a Hong Kong based biotech company that uses AI to develop new medicines as well as in anti-aging research. The application of AI in their\" \/>\n<meta property=\"og:url\" content=\"https:\/\/dailyai.com\/es\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/\" \/>\n<meta property=\"og:site_name\" content=\"DailyAI\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-04T08:09:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-05T08:09:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/AI-generated-drug-gets-human-trial-approval.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"563\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Eugene van der Watt\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DailyAIOfficial\" \/>\n<meta name=\"twitter:site\" content=\"@DailyAIOfficial\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Eugene van der Watt\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/\"},\"author\":{\"name\":\"Eugene van der Watt\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#\\\/schema\\\/person\\\/7ce525c6d0c79838b7cc7cde96993cfa\"},\"headline\":\"First AI-generated drug given go-ahead for human trials\",\"datePublished\":\"2023-07-04T08:09:00+00:00\",\"dateModified\":\"2023-07-05T08:09:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/\"},\"wordCount\":479,\"publisher\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/AI-generated-drug-gets-human-trial-approval.jpg\",\"keywords\":[\"AI benefits\",\"Generative AI\",\"MedTech\"],\"articleSection\":[\"Industry\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/\",\"url\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/\",\"name\":\"First AI-generated drug given go-ahead for human trials | DailyAI\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/AI-generated-drug-gets-human-trial-approval.jpg\",\"datePublished\":\"2023-07-04T08:09:00+00:00\",\"dateModified\":\"2023-07-05T08:09:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/#primaryimage\",\"url\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/AI-generated-drug-gets-human-trial-approval.jpg\",\"contentUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/AI-generated-drug-gets-human-trial-approval.jpg\",\"width\":1000,\"height\":563,\"caption\":\"AI generated drug gets human trial approval\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/2023\\\/07\\\/first-ai-generated-drug-given-go-ahead-for-human-trials\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/dailyai.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"First AI-generated drug given go-ahead for human trials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#website\",\"url\":\"https:\\\/\\\/dailyai.com\\\/\",\"name\":\"DailyAI\",\"description\":\"Your Daily Dose of AI News\",\"publisher\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dailyai.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#organization\",\"name\":\"DailyAI\",\"url\":\"https:\\\/\\\/dailyai.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Daily-Ai_TL_colour.png\",\"contentUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Daily-Ai_TL_colour.png\",\"width\":4501,\"height\":934,\"caption\":\"DailyAI\"},\"image\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/DailyAIOfficial\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/dailyaiofficial\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@DailyAIOfficial\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#\\\/schema\\\/person\\\/7ce525c6d0c79838b7cc7cde96993cfa\",\"name\":\"Eugene van der Watt\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Eugine_Profile_Picture-96x96.png\",\"url\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Eugine_Profile_Picture-96x96.png\",\"contentUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Eugine_Profile_Picture-96x96.png\",\"caption\":\"Eugene van der Watt\"},\"description\":\"Eugene comes from an electronic engineering background and loves all things tech. When he takes a break from consuming AI news you'll find him at the snooker table.\",\"sameAs\":[\"www.linkedin.com\\\/in\\\/eugene-van-der-watt-16828119\"],\"url\":\"https:\\\/\\\/dailyai.com\\\/es\\\/author\\\/eugene\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Primer f\u00e1rmaco generado por inteligencia artificial autorizado para ensayos en humanos | DailyAI","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/dailyai.com\/es\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/","og_locale":"es_ES","og_type":"article","og_title":"First AI-generated drug given go-ahead for human trials | DailyAI","og_description":"Insilico Medicine has been given approval for human trials of their completely AI-generated drug. The drug has been designed as a potential treatment for idiopathic pulmonary fibrosis (IPF) which is a degenerative disease that causes scarring and thickening of the lung tissues. IPF affects around 100,000 people in the US alone. The new drug, called INS018_055, will be trialed for 12 weeks in China with expanded trials planned for China and the US. Insilico is a Hong Kong based biotech company that uses AI to develop new medicines as well as in anti-aging research. The application of AI in their","og_url":"https:\/\/dailyai.com\/es\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/","og_site_name":"DailyAI","article_published_time":"2023-07-04T08:09:00+00:00","article_modified_time":"2023-07-05T08:09:37+00:00","og_image":[{"width":1000,"height":563,"url":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/AI-generated-drug-gets-human-trial-approval.jpg","type":"image\/jpeg"}],"author":"Eugene van der Watt","twitter_card":"summary_large_image","twitter_creator":"@DailyAIOfficial","twitter_site":"@DailyAIOfficial","twitter_misc":{"Escrito por":"Eugene van der Watt","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/#article","isPartOf":{"@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/"},"author":{"name":"Eugene van der Watt","@id":"https:\/\/dailyai.com\/#\/schema\/person\/7ce525c6d0c79838b7cc7cde96993cfa"},"headline":"First AI-generated drug given go-ahead for human trials","datePublished":"2023-07-04T08:09:00+00:00","dateModified":"2023-07-05T08:09:37+00:00","mainEntityOfPage":{"@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/"},"wordCount":479,"publisher":{"@id":"https:\/\/dailyai.com\/#organization"},"image":{"@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/AI-generated-drug-gets-human-trial-approval.jpg","keywords":["AI benefits","Generative AI","MedTech"],"articleSection":["Industry"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/","url":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/","name":"Primer f\u00e1rmaco generado por inteligencia artificial autorizado para ensayos en humanos | DailyAI","isPartOf":{"@id":"https:\/\/dailyai.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/#primaryimage"},"image":{"@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/AI-generated-drug-gets-human-trial-approval.jpg","datePublished":"2023-07-04T08:09:00+00:00","dateModified":"2023-07-05T08:09:37+00:00","breadcrumb":{"@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/#primaryimage","url":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/AI-generated-drug-gets-human-trial-approval.jpg","contentUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/AI-generated-drug-gets-human-trial-approval.jpg","width":1000,"height":563,"caption":"AI generated drug gets human trial approval"},{"@type":"BreadcrumbList","@id":"https:\/\/dailyai.com\/2023\/07\/first-ai-generated-drug-given-go-ahead-for-human-trials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/dailyai.com\/"},{"@type":"ListItem","position":2,"name":"First AI-generated drug given go-ahead for human trials"}]},{"@type":"WebSite","@id":"https:\/\/dailyai.com\/#website","url":"https:\/\/dailyai.com\/","name":"DailyAI","description":"Su dosis diaria de noticias sobre IA","publisher":{"@id":"https:\/\/dailyai.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dailyai.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/dailyai.com\/#organization","name":"DailyAI","url":"https:\/\/dailyai.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/dailyai.com\/#\/schema\/logo\/image\/","url":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/06\/Daily-Ai_TL_colour.png","contentUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/06\/Daily-Ai_TL_colour.png","width":4501,"height":934,"caption":"DailyAI"},"image":{"@id":"https:\/\/dailyai.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/DailyAIOfficial","https:\/\/www.linkedin.com\/company\/dailyaiofficial\/","https:\/\/www.youtube.com\/@DailyAIOfficial"]},{"@type":"Person","@id":"https:\/\/dailyai.com\/#\/schema\/person\/7ce525c6d0c79838b7cc7cde96993cfa","name":"Eugene van der Watt","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/Eugine_Profile_Picture-96x96.png","url":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/Eugine_Profile_Picture-96x96.png","contentUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/Eugine_Profile_Picture-96x96.png","caption":"Eugene van der Watt"},"description":"Eugene es ingeniero electr\u00f3nico y le encanta todo lo relacionado con la tecnolog\u00eda. Cuando descansa de consumir noticias sobre IA, lo encontrar\u00e1 jugando al billar.","sameAs":["www.linkedin.com\/in\/eugene-van-der-watt-16828119"],"url":"https:\/\/dailyai.com\/es\/author\/eugene\/"}]}},"_links":{"self":[{"href":"https:\/\/dailyai.com\/es\/wp-json\/wp\/v2\/posts\/2282","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dailyai.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailyai.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailyai.com\/es\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/dailyai.com\/es\/wp-json\/wp\/v2\/comments?post=2282"}],"version-history":[{"count":1,"href":"https:\/\/dailyai.com\/es\/wp-json\/wp\/v2\/posts\/2282\/revisions"}],"predecessor-version":[{"id":2284,"href":"https:\/\/dailyai.com\/es\/wp-json\/wp\/v2\/posts\/2282\/revisions\/2284"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailyai.com\/es\/wp-json\/wp\/v2\/media\/2283"}],"wp:attachment":[{"href":"https:\/\/dailyai.com\/es\/wp-json\/wp\/v2\/media?parent=2282"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailyai.com\/es\/wp-json\/wp\/v2\/categories?post=2282"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailyai.com\/es\/wp-json\/wp\/v2\/tags?post=2282"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}